Shomron Ben‐Horin - Concepedia

Author

Shomron Ben‐Horin

Also Known As

My-Linh Tran-Minh, S B Horin, S Ben - Horin, S Ben Horin, S Ben- Horin, S Ben-Horin, S Ben-Horin1, S Ben‐Horin, S. Ben Horin, S. Ben-Horin

596

Publications

16.9K

Citations

H-Index

128

Concepts

All Affiliations

Sheba Medical Center Tel Aviv University Rambam Health Care Campus Technion – Israel Institute of Technology Sun Yat-sen University

About

Shomron Ben‐Horin is an author at Sheba Medical Center specializing in medicine, gastroenterology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	59	4.4K
2	Public Health	8	8	395
3	Allergy	7	7	352
4	Engineering	5	5	461
5	Health Sciences	4	4	126

Shomron Ben‐Horin

190

Publications

12.2K

Citations

H-Index

Page 1

	Year	Citations
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease Jean‐François Rahier, Fernando Magro, Cândida Abreu, Journal of Crohn s and Colitis	2014	909
Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed Bruce E. Sands, Brian G. Feagan, Paul Rutgeerts, Gastroenterology	2014	689
Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial Alon Lang, Nir Salomon, Justin CY Wu, Clinical Gastroenterology and Hepatology InflammationAnti-inflammatoryMesalamine Induces RemissionMedicineGastroenterology	2015	412
Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases Bella Ungar, Idan Levy, Yarden Yavne, Clinical Gastroenterology and Hepatology InflammationRheumatologyMucosal HealingAnti-inflammatoryAutoimmune Disease	2015	360
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects Matthieu Allez, Konstantinos Κarmiris, Édouard Louis, Journal of Crohn s and Colitis InflammationRheumatologyChronic Inflammatory DiseasesAnti-inflammatoryAutoimmune Disease	2010	336
Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab Henit Yanai, Lev Lichtenstein, Amit Assa, Clinical Gastroenterology and Hepatology Anti-inflammatoryAutoimmune DiseaseImmunologyTherapeutic EfficacyPharmacotherapy	2014	306
Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease Shomron Ben‐Horin, Matti Waterman, Uri Kopylov, Clinical Gastroenterology and Hepatology InflammationChronic Inflammatory DiseasesAnti-inflammatoryAutoimmune DiseaseImmunology	2012	302
The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab Bella Ungar, Yehuda Chowers, Miri Yavzori, Gut	2013	298
Deep learning algorithms for automated detection of Crohn’s disease ulcers by video capsule endoscopy Eyal Klang, Yiftach Barash, Reuma Yehuda Margalit, Gastrointestinal Endoscopy Image ClassificationVideo Capsule EndoscopyImage AnalysisEndoscopic ImagingMachine Learning	2019	226
Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease Stefan Schreiber, Shomron Ben‐Horin, Jarosław Leszczyszyn, Gastroenterology InflammationAnti-inflammatoryControlled TrialGastroenterologySurgery	2021	216

Page 1